• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.

作者信息

Wiggins Barbara S, Saseen Joseph J, Page Robert L, Reed Brent N, Sneed Kevin, Kostis John B, Lanfear David, Virani Salim, Morris Pamela B

出版信息

Circulation. 2016 Nov 22;134(21):e468-e495. doi: 10.1161/CIR.0000000000000456. Epub 2016 Oct 17.

DOI:10.1161/CIR.0000000000000456
PMID:27754879
Abstract
摘要

相似文献

1
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.他汀类药物与心血管疾病患者使用的特定药物之间具有临床意义的药物相互作用的管理建议：美国心脏协会的科学声明
Circulation. 2016 Nov 22;134(21):e468-e495. doi: 10.1161/CIR.0000000000000456. Epub 2016 Oct 17.
2
Statins.他汀类药物
Vasc Med. 2017 Oct;22(5):442-445. doi: 10.1177/1358863X17722212. Epub 2017 Aug 12.
3
Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.心脏结局预防评估试验对他汀类药物用于心血管疾病一级预防的适用性影响：来自美国国家健康与营养检查调查的见解
Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102.
4
Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.2013年美国心脏病学会/美国心脏协会（ACC/AHA）胆固醇管理指南发布后两年内，美国一项大型医保计划中他汀类药物的起始使用模式
J Am Heart Assoc. 2017 May 4;6(5):e005205. doi: 10.1161/JAHA.116.005205.
5
The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.预防性药物悖论：共同决策如何可能增加心血管疾病的发病率和死亡率。
Circulation. 2016 Nov 22;134(21):1599-1600. doi: 10.1161/CIRCULATIONAHA.116.025204.
6
High-Quality Statin Trials Support the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines After the HOPE-3 Trial (Heart Outcomes Prevention Evaluation-3): MESA (The Multiethnic Study of Atherosclerosis).在HOPE-3试验（心脏结局预防评估-3）之后，高质量他汀类药物试验支持2013年美国心脏病学会/美国心脏协会胆固醇指南：动脉粥样硬化多民族研究（MESA）。
Circulation. 2017 Nov 7;136(19):1863-1865. doi: 10.1161/CIRCULATIONAHA.117.029381. Epub 2017 Jun 20.
7
Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.美国心脏病学会/美国心脏协会（ACC/AHA）胆固醇指南对几种美国社区卫生中心网络中糖尿病患者心血管疾病预防中他汀类药物未充分利用的影响。
J Am Heart Assoc. 2017 Jul 3;6(7):e005627. doi: 10.1161/JAHA.117.005627.
8
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.不同他汀类药物的耐受性及危害比较：一项基于135项随机对照试验中246955名参与者的研究水平网络荟萃分析
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):390-9. doi: 10.1161/CIRCOUTCOMES.111.000071. Epub 2013 Jul 9.
9
Comparing Guidelines for Statin Treatment in Canada and the United States.加拿大和美国他汀类药物治疗指南的比较
J Am Heart Assoc. 2015 Jul 14;4(7):e001758. doi: 10.1161/JAHA.114.001758.
10
American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).美国心脏病学会/美国心脏协会（ACC/AHA）降低动脉粥样硬化性心血管疾病风险的胆固醇治疗I类指南：基于西班牙裔社区健康研究/拉丁裔研究（HCHS/SOL）结果对美国西班牙裔/拉丁裔的影响
J Am Heart Assoc. 2017 May 11;6(5):e005045. doi: 10.1161/JAHA.116.005045.

引用本文的文献

1
Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes.他汀类药物在炎症和癌症治疗中的分子及免疫调节机制，重点关注核因子κB、NLRP3炎性小体和细胞因子调节轴
Int J Mol Sci. 2025 Aug 29;26(17):8429. doi: 10.3390/ijms26178429.
2
Molecular Aspects of Geriatric Pharmacotherapy.老年药物治疗的分子层面
Cells. 2025 Sep 1;14(17):1363. doi: 10.3390/cells14171363.
3
Target the Heart: A New Axis of Alzheimer's Disease Prevention.靶向心脏：阿尔茨海默病预防的新轴
J Dement Alzheimers Dis. 2025 Jun;2(2). doi: 10.3390/jdad2020010. Epub 2025 May 1.
4
Increased risk of rhabdomyolysis in patients using statins: a population-based case-control study.使用他汀类药物的患者发生横纹肌溶解症的风险增加：一项基于人群的病例对照研究。
Ther Adv Drug Saf. 2025 Aug 11;16:20420986251365746. doi: 10.1177/20420986251365746. eCollection 2025.
5
Drug-Drug Interactions Between Direct Oral Anticoagulants and Other Medications in Patients with Pulmonary Embolism: Results from the Lungenembolie Augsburg (LEA).直接口服抗凝剂与肺栓塞患者其他药物之间的药物相互作用：奥格斯堡肺栓塞（LEA）研究结果
Clin Pharmacokinet. 2025 Aug 9. doi: 10.1007/s40262-025-01556-7.
6
Ten-Year Trend in the Potentially Inappropriate Prescribing of Renally-Dependent Medicines in Australian General Practice Patients with Dementia.澳大利亚患有痴呆症的全科医疗患者中肾依赖性药物潜在不适当处方的十年趋势。
J Clin Med. 2025 Jul 4;14(13):4734. doi: 10.3390/jcm14134734.
7
Drug combination-wide association studies of cancer.癌症的药物联合全基因组关联研究。
Commun Med (Lond). 2025 Jul 9;5(1):285. doi: 10.1038/s43856-025-00991-8.
8
Determination of the latent geometry of atorvastatin pharmacokinetics by transfer entropy to identify bottlenecks.通过转移熵确定阿托伐他汀药代动力学的潜在几何结构以识别瓶颈
BMC Pharmacol Toxicol. 2025 Jun 25;26(Suppl 1):123. doi: 10.1186/s40360-025-00948-6.
9
Insights Into Atorvastatin Pharmacokinetics in Rats Reveal Regulation of CYP3A1 by Humanization of SLCO2B1.对大鼠阿托伐他汀药代动力学的深入研究揭示了通过人源化SLCO2B1对CYP3A1的调控。
Pharmacol Res Perspect. 2025 Aug;13(4):e70133. doi: 10.1002/prp2.70133.
10
Lipid-lowering statins and polyphenol-based supplementation: a scoping review on drug-food interaction potential.降脂他汀类药物与基于多酚的补充剂：关于药物-食物相互作用潜力的范围综述
Front Pharmacol. 2025 May 30;16:1541871. doi: 10.3389/fphar.2025.1541871. eCollection 2025.